Structures by: Wood P. A.
Total: 150
Pyrene 9,10-dicyanoanthracene
2(C8H4N),2(C8H5)
Chemical Science (2021)
a=7.3505(4)Å b=9.1897(6)Å c=17.0347(11)Å
α=94.567(6)° β=91.046(5)° γ=113.509(6)°
Bis-(6H-Benzo[c]chromen-6-one) pyrene
2(C13H8O2),2(C8H5)
Chemical Science (2021)
a=8.2950(5)Å b=16.3146(11)Å c=21.1379(18)Å
α=90° β=91.514(7)° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=5.14810(10)Å b=13.6138(2)Å c=7.74260(10)Å
α=90° β=90° γ=90°
C4H9NO3
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=5.0359(6)Å b=13.462(3)Å c=7.2375(16)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.879(3)Å b=13.135(8)Å c=6.658(6)Å
α=90° β=90° γ=90°
C4H9NO3
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=5.0055(2)Å b=13.4104(9)Å c=7.1162(4)Å
α=90° β=90° γ=90°
C4H9NO3
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=5.0694(10)Å b=13.492(6)Å c=7.403(4)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.933(2)Å b=13.248(9)Å c=6.841(3)Å
α=90° β=90° γ=90°
C4H9NO3
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.9824(6)Å b=13.353(3)Å c=7.0029(14)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.9715(14)Å b=13.236(7)Å c=7.042(2)Å
α=90° β=90° γ=90°
C4H9NO3
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.9154(9)Å b=13.230(5)Å c=6.7665(14)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.9383(19)Å b=13.250(5)Å c=6.841(3)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.773(3)Å b=12.910(8)Å c=6.363(6)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.799(2)Å b=12.972(5)Å c=6.432(3)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.771(3)Å b=12.903(6)Å c=6.361(4)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.842(6)Å b=13.025(17)Å c=6.589(12)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.823(4)Å b=13.027(10)Å c=6.481(7)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.735(5)Å b=12.823(13)Å c=6.275(8)Å
α=90° β=91.14(3)° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.620(9)Å b=12.52(2)Å c=6.037(14)Å
α=90° β=92.54(4)° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.823(5)Å b=13.025(12)Å c=6.457(8)Å
α=90° β=90° γ=90°
L-threonine
C4H9NO3
CrystEngComm (2019) 21, 30 4444
a=4.679(6)Å b=12.659(13)Å c=6.143(9)Å
α=90° β=91.42(3)° γ=90°
?
[Ni(C4HO3)0.223(Ne)]n
Chemical Communications (2016) 52, 10048-10051
a=25.7522(3)Å b=25.7522(3)Å c=6.7576(3)Å
α=90° β=90° γ=120°
?
[Cu2(C17H14N10O4)0.632(Ne)]n
Chemical Communications (2016) 52, 10048-10051
a=28.6841(11)Å b=9.2655(5)Å c=9.3005(4)Å
α=90° β=116.369(3)° γ=90°
?
[Ni(C4HO3)1.045(Ne)]n
Chemical Communications (2016) 52, 10048-10051
a=25.7611(4)Å b=25.7611(4)Å c=6.7565(3)Å
α=90° β=90° γ=120°
?
[Cu2(C17H14N10O4)0.358(Ne)]n
Chemical Communications (2016) 52, 10048-10051
a=28.7444(11)Å b=9.2672(5)Å c=9.3295(4)Å
α=90° β=116.097(3)° γ=90°
?
[Cu2(C17H14N10O4)0.892(Ne)]n
Chemical Communications (2016) 52, 10048-10051
a=28.6315(13)Å b=9.2743(5)Å c=9.2833(5)Å
α=90° β=116.615(4)° γ=90°
?
[Ni(C4HO3)0.46(Ne)]n
Chemical Communications (2016) 52, 10048-10051
a=25.7542(3)Å b=25.7542(3)Å c=6.7550(3)Å
α=90° β=90° γ=120°
Salicylaldoxime
C7H7N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=10.346(4)Å b=5.0294(17)Å c=13.478(5)Å
α=90° β=112.21(2)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=6.6132(3)Å b=13.1087(6)Å c=13.6382(6)Å
α=68.762(3)° β=76.739(3)° γ=79.733(3)°
3-Methylsalicylaldoxime
C8H9N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=13.249(4)Å b=3.9513(11)Å c=14.402(4)Å
α=90° β=90.324(4)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=13.1506(18)Å b=3.8859(6)Å c=14.3115(19)Å
α=90° β=91.548(10)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=13.1506(18)Å b=3.8859(6)Å c=14.3115(19)Å
α=90° β=91.548(10)° γ=90°
3-Methoxysalicylaldoxime
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=13.9108(5)Å b=7.1936(3)Å c=15.6965(6)Å
α=90° β=90° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.998(3)Å b=3.6988(5)Å c=13.9167(16)Å
α=90° β=90.99(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.941(4)Å b=3.6146(5)Å c=13.7188(17)Å
α=90° β=91.47(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.878(4)Å b=3.5363(5)Å c=13.5218(16)Å
α=90° β=91.88(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.831(3)Å b=3.5096(4)Å c=13.4462(13)Å
α=90° β=92.10(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.766(7)Å b=3.4872(9)Å c=13.382(3)Å
α=90° β=92.27(4)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=12.750(4)Å b=3.4482(6)Å c=13.2910(18)Å
α=90° β=92.45(2)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.811(3)Å b=6.4564(7)Å c=19.759(4)Å
α=90° β=94.060(8)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.5745(13)Å b=6.3779(4)Å c=19.0922(18)Å
α=90° β=94.882(4)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.3941(14)Å b=6.3329(4)Å c=18.7250(19)Å
α=90° β=95.325(5)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.271(4)Å b=6.3030(9)Å c=18.459(5)Å
α=90° β=95.590(15)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=14.101(3)Å b=6.2699(6)Å c=18.158(3)Å
α=90° β=95.817(10)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.843(3)Å b=3.6613(3)Å c=13.7921(16)Å
α=90° β=92.603(13)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.652(4)Å b=3.5295(4)Å c=13.509(2)Å
α=90° β=93.64(2)° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
CrystEngComm (2008) 10, 2 239
a=12.544(6)Å b=3.4424(8)Å c=13.365(5)Å
α=90° β=94.44(4)° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=13.0765(5)Å b=7.0982(4)Å c=15.2455(5)Å
α=90° β=90° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.3113(5)Å b=6.9800(4)Å c=14.8947(5)Å
α=90° β=90° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.5814(4)Å b=7.0265(4)Å c=15.0188(4)Å
α=90° β=90° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.1340(13)Å b=6.9421(11)Å c=14.8065(13)Å
α=90° β=90° γ=90°
C8H9N1O3
C8H9N1O3
CrystEngComm (2008) 10, 2 239
a=12.0702(5)Å b=6.9200(5)Å c=14.7703(5)Å
α=90° β=90° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=6.6132(3)Å b=13.1087(6)Å c=13.6382(6)Å
α=68.762(3)° β=76.739(3)° γ=79.733(3)°
3-tButylsalicylaldoxime
C11H15N1O2
CrystEngComm (2008) 10, 2 239
a=6.5597(7)Å b=12.8532(9)Å c=13.479(2)Å
α=69.311(10)° β=76.054(10)° γ=79.035(6)°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=8.57203(67)Å b=9.30117(49)Å c=5.60429(45)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=8.48770(68)Å b=9.09431(54)Å c=5.57539(47)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=8.44354(73)Å b=8.96414(56)Å c=5.55463(50)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=8.39175(69)Å b=8.80598(51)Å c=5.52187(50)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=8.35471(71)Å b=8.70622(53)Å c=5.49678(53)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=8.32162(60)Å b=8.62427(43)Å c=5.47386(41)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=8.30986(53)Å b=8.59508(39)Å c=5.46585(36)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=6.87000(33)Å b=9.63731(56)Å c=5.60664(30)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=6.81067(43)Å b=9.62266(69)Å c=5.59344(31)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=6.76267(42)Å b=9.60731(70)Å c=5.58248(37)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=6.68687(32)Å b=9.58023(58)Å c=5.56241(31)Å
α=90° β=90° γ=90°
L-serine-d7
C3D7NO3
CrystEngComm (2008) 10, 9 1154
a=6.54874(33)Å b=9.53864(54)Å c=5.60779(32)Å
α=90° β=90° γ=90°
[Pt(Bipy)(OAc)(N3)]
[Pt(Bipy)(OAc)(N3)]
Dalton Transactions (2009) 13 2315-2325
a=8.0488(4)Å b=14.1103(7)Å c=15.3280(7)Å
α=90.00° β=90.00° γ=90.00°
C12H8N8Pt1
C12H8N8Pt1
Dalton Transactions (2009) 13 2315-2325
a=19.3584(7)Å b=10.1802(4)Å c=13.8692(4)Å
α=90° β=113.816(2)° γ=90°
C10H8N8Pt1
C10H8N8Pt1
Dalton Transactions (2009) 13 2315-2325
a=10.9346(5)Å b=15.3328(8)Å c=7.0453(4)Å
α=90° β=94.717(3)° γ=90°
C10H10N8Pt1
C10H10N8Pt1
Dalton Transactions (2009) 13 2315-2325
a=11.6121(5)Å b=3.8371(2)Å c=14.1714(9)Å
α=90° β=102.756(2)° γ=90°
[Pt(phen)(N3)2(OAc)2]
[Pt(phen)(N3)2(OAc)2]
Dalton Transactions (2009) 13 2315-2325
a=7.03030(10)Å b=11.7849(2)Å c=11.3271(2)Å
α=90° β=101.2360(10)° γ=90°
3-Methoxysalicylaldoxime
C8H9N1O3
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=13.9108(5)Å b=7.1936(3)Å c=15.6965(6)Å
α=90° β=90° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
CrystEngComm (2008) 10, 2 239
a=13.249(4)Å b=3.9513(11)Å c=14.402(4)Å
α=90° β=90.324(4)° γ=90°
[Pt(py)2(OAc)2(N3)2]
[Pt(py)2(OAc)2(N3)2]
Dalton Transactions (2009) 13 2315-2325
a=6.9480(3)Å b=8.2197(4)Å c=8.6473(4)Å
α=92.136(3)° β=111.574(3)° γ=101.038(3)°
Salicylaldoxime
C7H7N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=10.346(4)Å b=5.0294(17)Å c=13.478(5)Å
α=90° β=112.21(2)° γ=90°
3-Methylsalicylaldoxime
C8H9N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=13.249(4)Å b=3.9513(11)Å c=14.402(4)Å
α=90° β=90.324(4)° γ=90°
3-tButylsalicylaldoxime
C11H15N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=6.6132(3)Å b=13.1087(6)Å c=13.6382(6)Å
α=68.762(3)° β=76.739(3)° γ=79.733(3)°
3-Methoxysalicylaldoxime
C8H9N1O3
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=13.9108(5)Å b=7.1936(3)Å c=15.6965(6)Å
α=90° β=90° γ=90°
3-chlorosalicylaldoxime
C7H6Cl1N1O2
Chemical Communications (Cambridge, United Kingdom) (2007) 46 4940-4942
a=13.1506(18)Å b=3.8859(6)Å c=14.3115(19)Å
α=90° β=91.548(10)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.8887(8)Å b=4.9700(3)Å c=20.9607(19)Å
α=90° β=91.546(4)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.7925(11)Å b=4.9356(5)Å c=20.415(5)Å
α=90° β=92.266(14)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.5438(6)Å b=4.8464(3)Å c=19.203(3)Å
α=90° β=93.648(7)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=12.3706(7)Å b=4.7918(3)Å c=18.398(3)Å
α=90° β=94.078(8)° γ=90°
Salicylamide
C7H7N1O2
CrystEngComm (2010) 12, 4 1065
a=3.8938(4)Å b=5.5612(6)Å c=28.566(8)Å
α=90° β=90° γ=90°
Ethylamine
C2H7N
CrystEngComm (2014) 16, 19 3867
a=8.97420(18)Å b=5.21927(8)Å c=7.40243(16)Å
α=90° β=112.9722(13)° γ=90°
Ethylamine
C2H7N1
CrystEngComm (2014) 16, 19 3867
a=8.2633(3)Å b=7.3098(3)Å c=5.5317(2)Å
α=90° β=99.088(3)° γ=90°
Propylamine
C3H9N1
CrystEngComm (2014) 16, 19 3867
a=23.2870(13)Å b=6.2354(4)Å c=5.9794(4)Å
α=90° β=90° γ=90°
Pentylamine
C5H13N1
CrystEngComm (2014) 16, 19 3867
a=33.546(4)Å b=6.4878(8)Å c=5.7295(7)Å
α=90° β=90° γ=90°
Butylamine
C4H11N1
CrystEngComm (2014) 16, 19 3867
a=26.7852(8)Å b=6.8166(2)Å c=5.6703(2)Å
α=90° β=90° γ=90°
Hexylamine
C6H15N1
CrystEngComm (2014) 16, 19 3867
a=6.9725(3)Å b=17.7977(6)Å c=5.6105(2)Å
α=90° β=90° γ=90°
Octylamine
C8H19N1
CrystEngComm (2014) 16, 19 3867
a=7.0309(5)Å b=22.3077(15)Å c=5.5826(4)Å
α=90° β=90° γ=90°
Decylamine
C10H23N1
CrystEngComm (2014) 16, 19 3867
a=7.0660(4)Å b=26.8352(15)Å c=5.5730(3)Å
α=90° β=90° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=10.346(4)Å b=5.0294(17)Å c=13.478(5)Å
α=90° β=112.21(2)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=10.1833(16)Å b=4.9766(3)Å c=13.0109(15)Å
α=90° β=111.938(10)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.7148(16)Å b=4.9322(3)Å c=12.0145(16)Å
α=90° β=110.607(11)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.5728(15)Å b=4.9342(3)Å c=11.7537(15)Å
α=90° β=110.064(10)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=9.513(2)Å b=4.9319(4)Å c=11.630(2)Å
α=90° β=109.859(14)° γ=90°
Salicylaldoxime
C7H7N1O2
Acta Crystallographica Section B (2006) 62, 6 1099-1111
a=7.677(3)Å b=5.7731(8)Å c=12.159(3)Å
α=90° β=110.62(2)° γ=90°